首页> 美国卫生研究院文献>Plastic and Reconstructive Surgery Global Open >Systematic Review of Soft-tissue Filler–associated Blindness: A Methodologic Concern Beyond Duplicated Cases
【2h】

Systematic Review of Soft-tissue Filler–associated Blindness: A Methodologic Concern Beyond Duplicated Cases

机译:系统评价的软组织填充物相关的失明:重复病例之外的方法论问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently found published an article by Chatrath et al, entitled “Soft-tissue Filler–associated Blindness: A Systematic Review of Case Reports and Case Series,” in the last issue of the Journal. We read this valuable article with a great interest. The article emphasized an important and critical complication associated to filler and fat injection, blindness-associated filler injection, and aimed to review the cases of fillers in causing blindness and the association between hyaluronic acid filler and fat injection with blindness. The usage of soft-tissue fillers is growing, and these compounds are associated with certain adverse effects from minor local adverse effects to catastrophic vascular occlusive adverse effects such as blindness. Hence, it is necessary to address these adverse effects and the authors chose systematic review as a gold standard for this purpose. Systematic reviews and meta-analyses are crucial to summarize pervious published evidence relating to efficacy and safety of health care interventions accurately and reliably. It is necessary to follow certain guidelines for conducting a systematic review. Currently, Preferred Reporting Items for Systematic Reviews and Meta-Analyses is a well-known statement in this regard. According to this statement, the authors should screen the results of their search to avoid any duplicated results. Also, the authors should exclude the previous review articles from their search result. The duplicated results can falsify the final conclusion. Chatrath et al included a review article in their results which was published previously by Lazzeri et al. This article summarized 32 cases of blindness following cosmetic injections of the face. However, Chatrath et al included again these 32 cases. This duplication falsified the results, and with respect to the valuable study of Chatrath et al, the results should be interpreted again. In addition to utilizing some software (eg, EndNote) to remove duplicated results, it is recommended to screen each result including cases one by one to avoid such fundamental mistakes.
机译:最近,我们在《华尔街日报》的上一期中发现了Chatrath等人发表的文章“软组织填充物相关的失明:病例报告和病例系列的系统评价”。我们非常感兴趣地阅读了这篇有价值的文章。这篇文章强调了与填充剂和脂肪注射剂相关的重要和关键的并发症,与盲目性相关的填充剂注射剂,并旨在回顾填充剂导致失明的情况以及透明质酸填充剂和脂肪注射剂与盲目性之间的关联。软组织填充剂的使用正在增长,并且这些化合物与某些不良反应相关,从轻微的局部不良反应到灾难性的血管闭塞性不良反应,例如失明。因此,有必要解决这些不利影响,并且作者为此选择了系统的评价作为黄金标准。系统的审查和荟萃分析对于准确,可靠地总结与医疗保健干预措施的有效性和安全性相关的以往公开证据至关重要。有必要遵循某些准则进行系统的审查。当前,在这方面众所周知的系统评价和元分析首选报告项目。根据此声明,作者应筛选搜索结果,以避免任何重复的结果。另外,作者应从搜索结果中排除以前的评论文章。重复的结果可能会歪曲最终结论。 Chatrath等人的研究结果中包括了一篇评论文章,该文章先前由Lazzeri等人发表。本文总结了面部整容注射后失明的32例病例。但是,Chatrath等人再次包括了这32例病例。这种重复篡改了结果,对于Chatrath等人的有价值的研究,应该再次解释结果。除了利用某些软件(例如EndNote)删除重复的结果外,建议逐个筛选包括案例在内的每个结果,以避免此类基本错误。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号